Seminario web
The evolving policy landscape
New policy frameworks across U.S. and EU markets are driving shifts in access, affordability, and innovation. From the U.S. IRA, MFN, and 340B programs to the EU HTA Regulation and Biotech Act, manufacturers face rapidly changing expectations that influence pricing, evidence planning, and launch sequencing. Watch the webinar recording to learn from our experts on the latest policy shifts and what they mean for access, pricing, and manufacturer strategy in the year ahead.
Key highlights
- Decode major 2025–2026 policy developments impacting access.
- Identify early implications for manufacturer strategy and patient access.
- Understand what changes in U.S. and EU policy mean for pricing and negotiation.
- Prepare for future compliance, engagement, and evidence submission challenges.
Moderator:
Chelsey Campbell, Senior Director, Commercial Excellence, Cencora
Speakers:
Jennifer Snow, Founder, Apteka
Casper Paardekooper, VP, Head of Pricing, Policy & Stakeholder Engagement, Europe, Cencora
Access the recording to learn more and stay ahead in an evolving global healthcare environment
Pardot Form
